Overview

Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) Patients

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
We hypothesize that ongoing and more severe airway inflammation in COPD may result from the impairment in activation of innate immune response
Phase:
Phase 3
Details
Lead Sponsor:
Mahidol University
Collaborator:
National Science and Technology Development Agency, Thailand
Treatments:
Budesonide